Zkusit zdarma
Replimune Group, Inc.

Replimune Group, Inc.

REPL
Cena:
$ 4.91
-0.31 (-5.94%)
Valuace
70
Růst
0
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Replimune Group, Inc. - REPL

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Replimune Group, Inc. - REPL

16:40 21-05-2026

NEW YORK, May 21, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors ...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Replimune Group, Inc. - REPL

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Replimune Group, Inc. - REPL

18:07 19-05-2026

NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of invest...

REPL Investors Have Opportunity to Join Replimune Group, Inc. Fraud Investigation with the Schall Law Firm

REPL Investors Have Opportunity to Join Replimune Group, Inc. Fraud Investigation with the Schall Law Firm

21:49 17-05-2026

LOS ANGELES, May 17, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights lit...

REPL Investors Have Opportunity to Join Replimune Group, Inc. Fraud Investigation with the Schall Law Firm

REPL Investors Have Opportunity to Join Replimune Group, Inc. Fraud Investigation with the Schall Law Firm

21:49 17-05-2026

LOS ANGELES, May 17, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights lit...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Replimune Group, Inc. - REPL

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Replimune Group, Inc. - REPL

20:15 14-05-2026

NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors ...

Replimune: Perhaps The FDA Shakeup Will Get A Mulligan For RP1

Replimune: Perhaps The FDA Shakeup Will Get A Mulligan For RP1

13:00 13-05-2026

Replimune Group, Inc.'s RP1 has failed at the FDA twice, but Makary's resignation keeps a resubmissi...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Replimune Group, Inc. – REPL

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Replimune Group, Inc. – REPL

17:24 12-05-2026

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of invest...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Replimune Group, Inc. - REPL

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Replimune Group, Inc. - REPL

10:00 07-05-2026

NEW YORK, May 7, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors o...

What's Going On With Replimune Stock On Tuesday?

What's Going On With Replimune Stock On Tuesday?

13:44 05-05-2026

U.S. Food and Drug Administration (FDA) Commissioner Marty Makary defended his leadership in a CNBC ...

FDA Commissioner Makary defends agency's decision on Replimune's drug

FDA Commissioner Makary defends agency's decision on Replimune's drug

10:58 05-05-2026

U.S. Food and Drug ​Administration Commissioner Dr. ‌Marty Makary on Tuesday defended ​the age...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Replimune Group, Inc. - REPL

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Replimune Group, Inc. - REPL

21:42 30-04-2026

NEW YORK, April 30, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investor...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Replimune Group, Inc. - REPL

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Replimune Group, Inc. - REPL

17:25 28-04-2026

NEW YORK, April 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inve...

US Health Secretary Kennedy distances himself from FDA's Replimune cancer drug rejection

US Health Secretary Kennedy distances himself from FDA's Replimune cancer drug rejection

12:56 22-04-2026

Health Secretary Robert F. Kennedy Jr. told ​a Senate hearing on Wednesday that he had nothing to ...

FDA Rejection Sparks Questions On Replimune Drug Approval Path

FDA Rejection Sparks Questions On Replimune Drug Approval Path

13:44 13-04-2026

Replimune Group Inc. (NASDAQ: REPL) on Friday received a Complete Response Letter (CRL) from the U.S...

Replimune Gets Second FDA CRL for Melanoma Drug BLA, Stock Crashes

Replimune Gets Second FDA CRL for Melanoma Drug BLA, Stock Crashes

12:35 13-04-2026

REPL stock plunges after a second FDA CRL delays RP1 melanoma approval, casting doubt on its regulat...

Replimune melanoma therapy rejected by FDA, shares plunge

Replimune melanoma therapy rejected by FDA, shares plunge

11:46 13-04-2026

Replimune Group (NASDAQ:REPL) shares fell roughly 63% following the company's disclosure that it re...

Replimune co-founder calls FDA rejection of melanoma drug ‘unfair'

Replimune co-founder calls FDA rejection of melanoma drug ‘unfair'

11:46 13-04-2026

Philip Astley-Sparke, executive chairman and co-founder at Replimune, joins ‘Squawk on the Street'...

Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma

Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma

17:02 10-04-2026

WOBURN, Mass., April 10, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical s...

US FDA declines to approve Replimune's drug for advanced skin cancer

US FDA declines to approve Replimune's drug for advanced skin cancer

11:24 10-04-2026

The ​U.S. ‌Food and ​Drug ​Administration ⁠on ​Friday declined ​to approve ​Replimun...

Replimune Group (NASDAQ:REPL) Insider Christopher Sarchi Sells 6,500 Shares of Stock

Replimune Group (NASDAQ:REPL) Insider Christopher Sarchi Sells 6,500 Shares of Stock

4:59 07-04-2026

Replimune Group, Inc. (NASDAQ: REPL - Get Free Report) insider Christopher Sarchi sold 6,500 shares ...

close

REPLIMUNE REPORTS FISCAL THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

03-02-2026
WOBURN, MASS., FEB. 03, 2026 (GLOBE NEWSWIRE) -- REPLIMUNE GROUP, INC. (NASDAQ: REPL), A CLINICAL ST...
Více zde

REPLIMUNE TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

18-12-2025
WOBURN, MASS., DEC. 18, 2025 (GLOBE NEWSWIRE) -- REPLIMUNE GROUP, INC. (NASDAQ: REPL), A CLINICAL ST...
Více zde

REPLIMUNE PRESENTS LATE-BREAKING ABSTRACT AND ADDITIONAL POSTERS ON RP1 AT 40TH ANNUAL MEETING OF THE SOCIETY FOR THE IMMUNOTHERAPY OF CANCER (SITC 2025)

07-11-2025
ORAL PRESENTATION OF BIOMARKER DATA SHOWS RP1 PLUS NIVOLUMAB REVERSES MULTIPLE RESISTANCE MECHANISMS...
Více zde

REPLIMUNE REPORTS FISCAL SECOND QUARTER 2026 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

06-11-2025
WOBURN, MASS., NOV. 06, 2025 (GLOBE NEWSWIRE) -- REPLIMUNE GROUP, INC. (NASDAQ: REPL), A CLINICAL ST...
Více zde

REPLIMUNE ANNOUNCES FDA ACCEPTANCE OF BLA RESUBMISSION OF RP1 FOR THE TREATMENT OF ADVANCED MELANOMA

20-10-2025
PRESCRIPTION DRUG USER FEE ACT (PDUFA) TARGET ACTION DATE SET FOR APRIL 10, 2026 PRESCRIPTION DRUG U...
Více zde

REPLIMUNE HIGHLIGHTS ACRAL MELANOMA DATA FOR RP1 PLUS NIVOLUMAB AT THE ESMO CONGRESS 2025

19-10-2025
WOBURN, MASS., OCT. 19, 2025 (GLOBE NEWSWIRE) -- REPLIMUNE GROUP, INC. (NASDAQ: REPL), A CLINICAL ST...
Více zde

REPLIMUNE ALERT: BRAGAR EAGEL & SQUIRE, P.C. IS INVESTIGATING REPLIMUNE GROUP, INC. ON BEHALF OF LONG-TERM STOCKHOLDERS AND ENCOURAGES INVESTORS TO CONTACT THE FIRM

08-10-2025
BRAGAR EAGEL & SQUIRE, P.C.  LITIGATION PARTNER  BRANDON WALKER  ENCOURAGES INVESTORS WHO SUFFERE...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM REMINDS INVESTORS WITH LOSSES ON THEIR INVESTMENT IN REPLIMUNE GROUP, INC. OF CLASS ACTION LAWSUIT AND UPCOMING DEADLINES - REPL

23-09-2025
NEW YORK , SEPT. 23, 2025 /PRNEWSWIRE/ -- POMERANTZ LLP ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BE...
Více zde

INVESTORS IN REPLIMUNE GROUP, INC. SHOULD CONTACT LEVI & KORSINSKY BEFORE SEPTEMBER 22, 2025 TO DISCUSS YOUR RIGHTS – REPL

22-09-2025
NEW YORK, SEPT. 22, 2025 (GLOBE NEWSWIRE) -- LEVI & KORSINSKY, LLP NOTIFIES INVESTORS IN REPLIMUNE G...
Více zde

FINAL DEADLINE ALERT: FARUQI & FARUQI, LLP INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF REPLIMUNE

22-09-2025
NEW YORK--(BUSINESS WIRE)---- $REPL #CLASSACTION--FARUQI & FARUQI, LLP, A LEADING NATIONAL SECURITIE...
Více zde

REPL DEADLINE: REPL INVESTORS WITH LOSSES IN EXCESS OF $100K HAVE OPPORTUNITY TO LEAD REPLIMUNE GROUP, INC. SECURITIES LAWSUIT FILED BY THE ROSEN LAW FIRM

22-09-2025
NEW YORK , SEPT. 22, 2025 /PRNEWSWIRE/ -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, RE...
Více zde

REPLIMUNE GROUP, INC. SECURITIES FRAUD CLASS ACTION LAWSUIT PENDING: CONTACT THE GROSS LAW FIRM BEFORE SEPTEMBER 22, 2025 TO DISCUSS YOUR RIGHTS - REPL

22-09-2025
NEW YORK , SEPT. 22, 2025 /PRNEWSWIRE/ -- THE GROSS LAW FIRM ISSUES THE FOLLOWING NOTICE TO SHAREHOL...
Více zde

REPLIMUNE GROUP, INC. SUED FOR SECURITIES LAW VIOLATIONS - CONTACT THE DJS LAW GROUP TO DISCUSS YOUR RIGHTS - REPL

22-09-2025
LOS ANGELES , SEPT. 22, 2025 /PRNEWSWIRE/ -- THE DJS LAW GROUP  REMINDS INVESTORS OF A CLASS ACTION...
Více zde

REPL INVESTORS HAVE OPPORTUNITY TO LEAD REPLIMUNE GROUP, INC. SECURITIES FRAUD LAWSUIT WITH THE SCHALL LAW FIRM

22-09-2025
LOS ANGELES , SEPT. 22, 2025 /PRNEWSWIRE/ -- THE SCHALL LAW FIRM , A NATIONAL SHAREHOLDER RIGHTS LIT...
Více zde

REPL INVESTOR ALERT: BRONSTEIN, GEWIRTZ & GROSSMAN LLC ANNOUNCES THAT REPLIMUNE GROUP, INC. INVESTORS WITH SUBSTANTIAL LOSSES HAVE OPPORTUNITY TO LEAD CLASS ACTION LAWSUIT

21-09-2025
NEW YORK, SEPT. 21, 2025 (GLOBE NEWSWIRE) -- ATTORNEY ADVERTISING -- BRONSTEIN, GEWIRTZ & GROSSMAN, ...
Více zde

REPL FINAL DEADLINE ALERT: REPLIMUNE (REPL) SHARES TANK 45% AFTER COMPANY SAYS NO PATHWAY IDENTIFIED FOR LEAD DRUG RP1, SECURITIES CLASS ACTION PENDING - HAGENS BERMAN

21-09-2025
REPL INVESTORS WITH LOSSES ENCOURAGED TO CONTACT THE FIRM BEFORE SEPT. 22ND DEADLINE REPL INVESTORS ...
Více zde

SHAREHOLDER NOTICE: FARUQI & FARUQI, LLP INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF REPLIMUNE

21-09-2025
FARUQI & FARUQI, LLP SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFF...
Více zde

REPL DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, ENCOURAGES REPLIMUNE GROUP, INC. INVESTORS WITH LOSSES IN EXCESS OF $100K TO SECURE COUNSEL BEFORE IMPORTANT DEADLINE IN SECURITIES CLASS ACTION FIRST FILED BY THE FIRM – REPL

21-09-2025
NEW YORK, SEPT. 21, 2025 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM...
Více zde

REPL DEADLINE: ROSEN LAW FIRM ENCOURAGES REPLIMUNE GROUP, INC. INVESTORS WITH LOSSES IN EXCESS OF $100K TO SECURE COUNSEL BEFORE IMPORTANT SEPTEMBER 22 DEADLINE IN SECURITIES CLASS ACTION FIRST FILED BY THE FIRM – REPL

20-09-2025
NEW YORK--(BUSINESS WIRE)--WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASER...
Více zde

REPLIMUNE (REPL) SHARES TANK 45% AFTER COMPANY SAYS NO PATHWAY IDENTIFIED FOR LEAD DRUG RP1, SECURITIES CLASS ACTION PENDING - HAGENS BERMAN

20-09-2025
REPL INVESTORS WITH LOSSES ENCOURAGED TO CONTACT THE FIRM BEFORE SEPT. 22ND DEADLINE SAN FRANCISCO ,...
Více zde

CLASS ACTION FILED AGAINST REPLIMUNE GROUP, INC. (REPL) SEEKING RECOVERY FOR INVESTORS – CONTACT LEVI & KORSINSKY

19-09-2025
NEW YORK, SEPT. 19, 2025 (GLOBE NEWSWIRE) -- LEVI & KORSINSKY, LLP NOTIFIES INVESTORS IN REPLIMUNE G...
Více zde

REPLIMUNE ALERT: BRAGAR EAGEL & SQUIRE, P.C. REMINDS INVESTORS THAT A CLASS ACTION LAWSUIT HAS BEEN FILED AGAINST REPLIMUNE GROUP, INC. AND ENCOURAGES INVESTORS TO CONTACT THE FIRM BEFORE SEPTEMBER 22ND

19-09-2025
ALLEGEDLY, DEFENDANTS OVERSTATED IGNYTE TRIAL PROSPECTS DESPITE ISSUES THAT LED THE FDA TO DEEM IT I...
Více zde

SHAREHOLDERS THAT LOST MONEY ON REPLIMUNE GROUP, INC.(REPL) SHOULD CONTACT LEVI & KORSINSKY ABOUT PENDING CLASS ACTION - REPL

19-09-2025
NEW YORK , SEPT. 19, 2025 /PRNEWSWIRE/ -- LEVI & KORSINSKY, LLP NOTIFIES INVESTORS IN REPLIMUNE GR...
Více zde

FARUQI & FARUQI REMINDS REPLIMUNE INVESTORS OF THE PENDING CLASS ACTION LAWSUIT WITH A LEAD PLAINTIFF DEADLINE OF SEPTEMBER 22, 2025 - REPL

18-09-2025
FARUQI & FARUQI, LLP SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFF...
Více zde

SHAREHOLDERS THAT LOST MONEY ON REPLIMUNE GROUP, INC. (REPL) URGED TO JOIN CLASS ACTION – CONTACT THE GROSS LAW FIRM TO LEARN MORE

18-09-2025
NEW YORK, SEPT. 18, 2025 (GLOBE NEWSWIRE) -- THE GROSS LAW FIRM ISSUES THE FOLLOWING NOTICE TO SHARE...
Více zde

REPLIMUNE (REPL) SHARES TANK 45% AFTER COMPANY SAYS NO PATHWAY IDENTIFIED FOR LEAD DRUG RP1, SECURITIES CLASS ACTION PENDING - HAGENS BERMAN

18-09-2025
REPL INVESTORS WITH LOSSES ENCOURAGED TO CONTACT THE FIRM BEFORE SEPT. 22ND DEADLINE SAN FRANCISCO ,...
Více zde

REPLIMUNE GROUP, INC. INVESTORS: PLEASE CONTACT THE PORTNOY LAW FIRM TO RECOVER YOUR LOSSES. SEPTEMBER 22, 2025 DEADLINE TO FILE LEAD PLAINTIFF MOTION.

18-09-2025
INVESTORS CAN CONTACT THE LAW FIRM AT NO COST TO LEARN MORE ABOUT RECOVERING THEIR LOSSES...
Více zde

BREAKING: REPLIMUNE SHARES DROP OVER 40%; INVESTORS SHOULD CONTACT BLOCK & LEVITON BY SEPTEMBER 22ND TO JOIN SECURITIES FRAUD LAWSUIT

18-09-2025
BOSTON, SEPT. 18, 2025 (GLOBE NEWSWIRE) -- BLOCK & LEVITON REMINDS INVESTORS THAT A SECURITIES FRAUD...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM REMINDS INVESTORS WITH LOSSES ON THEIR INVESTMENT IN REPLIMUNE GROUP, INC. OF CLASS ACTION LAWSUIT AND UPCOMING DEADLINES - REPL

18-09-2025
NEW YORK , SEPT. 18, 2025 /PRNEWSWIRE/ -- POMERANTZ LLP ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BE...
Více zde

REPLIMUNE PROVIDES UPDATE FOLLOWING TYPE A MEETING WITH FDA

18-09-2025
WOBURN, MASS., SEPT. 18, 2025 (GLOBE NEWSWIRE) -- REPLIMUNE GROUP, INC. (NASDAQ: REPL), A CLINICAL S...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-02-03 00:00:008-KStáhnout
2026-02-03 00:00:0010-QStáhnout
2026-01-12 00:00:008-KStáhnout
2025-11-06 00:00:008-KStáhnout
2025-11-06 00:00:0010-QStáhnout
2025-10-20 01:00:008-KStáhnout
2025-10-20 00:00:008-KStáhnout
2025-09-18 01:00:008-KStáhnout
2025-09-18 00:00:008-KStáhnout
2025-09-04 01:00:008-KStáhnout
2025-09-04 00:00:008-KStáhnout
2025-08-07 01:00:008-KStáhnout
2025-08-07 01:00:0010-QStáhnout
2025-08-07 00:00:008-KStáhnout
2025-08-07 00:00:0010-QStáhnout
2025-07-22 01:00:008-KStáhnout
2025-07-22 00:00:008-KStáhnout
2025-06-24 01:00:008-KStáhnout
2025-06-24 00:00:008-KStáhnout
2025-05-22 01:00:008-KStáhnout
2025-05-22 01:00:0010-KStáhnout
2025-05-22 00:00:008-KStáhnout
2025-05-22 00:00:0010-KStáhnout
2025-03-07 00:00:008-KStáhnout
2025-03-06 23:00:008-KStáhnout
2025-02-12 00:00:008-KStáhnout
2025-02-12 00:00:0010-QStáhnout
2025-02-11 23:00:008-KStáhnout
2025-02-11 23:00:0010-QStáhnout
2025-01-22 00:00:008-KStáhnout
2025-01-21 23:00:008-KStáhnout
2024-11-27 00:00:008-KStáhnout
2024-11-26 23:00:008-KStáhnout
2024-11-26 00:00:008-KStáhnout
2024-11-25 23:00:008-KStáhnout
2024-11-21 00:00:008-KStáhnout
2024-11-20 23:00:008-KStáhnout
2024-11-12 00:00:0010-QStáhnout
2024-11-11 23:00:0010-QStáhnout
2024-09-05 01:00:008-KStáhnout
2024-09-05 00:00:008-KStáhnout
2024-08-08 01:00:008-KStáhnout
2024-08-08 01:00:0010-QStáhnout
2024-08-08 00:00:008-KStáhnout
2024-08-08 00:00:0010-QStáhnout
2024-06-13 01:00:008-KStáhnout
2024-06-13 00:00:008-KStáhnout
2024-06-06 01:00:008-KStáhnout
2024-06-06 00:00:008-KStáhnout
2024-06-03 01:00:008-KStáhnout
2024-06-03 00:00:008-KStáhnout
2024-05-16 01:00:008-KStáhnout
2024-05-16 01:00:0010-KStáhnout
2024-05-16 00:00:008-KStáhnout
2024-05-16 00:00:0010-KStáhnout
2024-03-26 00:00:008-KStáhnout
2024-03-25 23:00:008-KStáhnout
2024-02-08 00:00:008-KStáhnout
2024-02-08 00:00:0010-QStáhnout
2024-02-07 23:00:008-KStáhnout
2024-02-07 23:00:0010-QStáhnout
2024-01-08 00:00:008-KStáhnout
2024-01-07 23:00:008-KStáhnout
2023-12-26 00:00:008-KStáhnout
2023-12-25 23:00:008-KStáhnout
2023-12-05 00:00:008-KStáhnout
2023-12-04 23:00:008-KStáhnout
2023-11-07 00:00:008-KStáhnout
2023-11-07 00:00:0010-QStáhnout
2023-11-06 23:00:008-KStáhnout
2023-11-06 23:00:0010-QStáhnout
2023-09-19 01:00:008-KStáhnout
2023-09-19 00:00:008-KStáhnout
2023-09-07 01:00:008-KStáhnout
2023-09-07 00:00:008-KStáhnout
2023-08-03 01:00:008-KStáhnout
2023-08-03 01:00:0010-QStáhnout
2023-08-03 00:00:008-KStáhnout
2023-08-03 00:00:0010-QStáhnout
2023-07-20 01:00:008-KStáhnout
2023-07-20 00:00:008-KStáhnout
2023-06-05 01:00:008-KStáhnout
2023-06-05 00:00:008-KStáhnout
2023-05-18 01:00:008-KStáhnout
2023-05-18 01:00:0010-KStáhnout
2023-05-18 00:00:008-KStáhnout
2023-05-18 00:00:0010-KStáhnout
2023-02-27 00:00:008-KStáhnout
2023-02-26 23:00:008-KStáhnout
2023-02-09 00:00:008-KStáhnout
2023-02-09 00:00:0010-QStáhnout
2023-02-08 23:00:008-KStáhnout
2023-02-08 23:00:0010-QStáhnout
2023-01-04 00:00:008-KStáhnout
2023-01-03 23:00:008-KStáhnout
2022-12-12 00:00:008-KStáhnout
2022-12-11 23:00:008-KStáhnout
2022-12-07 00:00:008-KStáhnout
2022-12-06 23:00:008-KStáhnout
2022-11-03 00:00:008-KStáhnout
2022-11-03 00:00:0010-QStáhnout
2022-11-02 23:00:008-KStáhnout
2022-11-02 23:00:0010-QStáhnout
2022-10-07 01:00:008-KStáhnout
2022-10-07 00:00:008-KStáhnout
2022-09-08 01:00:008-KStáhnout
2022-09-08 00:00:008-KStáhnout
2022-08-04 01:00:008-KStáhnout
2022-08-04 01:00:0010-QStáhnout
2022-08-04 00:00:008-KStáhnout
2022-08-04 00:00:0010-QStáhnout
2022-06-23 01:00:008-KStáhnout
2022-06-23 00:00:008-KStáhnout
2022-06-03 01:00:008-KStáhnout
2022-06-03 00:00:008-KStáhnout
2022-05-19 01:00:008-KStáhnout
2022-05-19 01:00:0010-KStáhnout
2022-05-19 00:00:008-KStáhnout
2022-05-19 00:00:0010-KStáhnout
2022-03-30 01:00:008-KStáhnout
2022-03-30 00:00:008-KStáhnout
2022-02-03 00:00:008-KStáhnout
2022-02-03 00:00:0010-QStáhnout
2022-02-02 23:00:008-KStáhnout
2022-02-02 23:00:0010-QStáhnout
2022-01-31 00:00:008-KStáhnout
2022-01-30 23:00:008-KStáhnout
2022-01-10 00:00:008-KStáhnout
2022-01-09 23:00:008-KStáhnout
2021-12-02 00:00:008-KStáhnout
2021-12-01 23:00:008-KStáhnout
2021-11-04 00:00:008-KStáhnout
2021-11-04 00:00:0010-QStáhnout
2021-11-03 23:00:008-KStáhnout
2021-11-03 23:00:0010-QStáhnout
2021-09-09 01:00:008-KStáhnout
2021-09-09 00:00:008-KStáhnout
2021-08-25 01:00:008-KStáhnout
2021-08-25 00:00:008-KStáhnout
2021-08-06 01:00:008-KStáhnout
2021-08-06 01:00:0010-QStáhnout
2021-08-06 00:00:008-KStáhnout
2021-08-06 00:00:0010-QStáhnout
2021-06-03 01:00:008-KStáhnout
2021-06-03 00:00:008-KStáhnout
2021-05-20 01:00:008-KStáhnout
2021-05-20 01:00:0010-KStáhnout
2021-05-20 00:00:008-KStáhnout
2021-05-20 00:00:0010-KStáhnout
2021-05-10 01:00:008-KStáhnout
2021-05-10 00:00:008-KStáhnout
2021-05-05 01:00:008-KStáhnout
2021-05-05 00:00:008-KStáhnout
2021-04-21 01:00:008-KStáhnout
2021-04-21 00:00:008-KStáhnout
2021-04-12 01:00:008-KStáhnout
2021-04-12 00:00:008-KStáhnout
2021-02-04 00:00:008-KStáhnout
2021-02-04 00:00:0010-QStáhnout
2021-02-03 23:00:008-KStáhnout
2021-02-03 23:00:0010-QStáhnout
2021-01-11 00:00:008-KStáhnout
2021-01-10 23:00:008-KStáhnout
2020-12-21 00:00:008-KStáhnout
2020-12-20 23:00:008-KStáhnout
2020-11-05 00:00:008-KStáhnout
2020-11-05 00:00:0010-QStáhnout
2020-11-04 23:00:008-KStáhnout
2020-11-04 23:00:0010-QStáhnout
2020-10-23 01:00:008-KStáhnout
2020-10-23 00:00:008-KStáhnout
2020-10-22 01:00:008-KStáhnout
2020-10-22 00:00:008-KStáhnout
2020-10-20 01:00:008-KStáhnout
2020-10-20 00:00:008-KStáhnout
2020-10-19 01:00:008-KStáhnout
2020-10-19 00:00:008-KStáhnout
2020-10-14 01:00:008-KStáhnout
2020-10-14 00:00:008-KStáhnout
2020-09-10 01:00:008-KStáhnout
2020-09-10 00:00:008-KStáhnout
2020-08-11 01:00:008-KStáhnout
2020-08-11 00:00:008-KStáhnout
2020-08-07 01:00:008-KStáhnout
2020-08-07 01:00:0010-QStáhnout
2020-08-07 00:00:008-KStáhnout
2020-08-07 00:00:0010-QStáhnout
2020-07-22 01:00:008-KStáhnout
2020-07-22 00:00:008-KStáhnout
2020-07-01 01:00:008-KStáhnout
2020-07-01 00:00:008-KStáhnout
2020-06-10 01:00:008-KStáhnout
2020-06-10 00:00:008-KStáhnout
2020-06-08 01:00:008-KStáhnout
2020-06-08 00:00:008-KStáhnout
2020-06-03 01:00:008-KStáhnout
2020-06-03 01:00:0010-KStáhnout
2020-06-03 00:00:008-KStáhnout
2020-06-03 00:00:0010-KStáhnout
2020-04-06 01:00:008-KStáhnout
2020-04-06 00:00:008-KStáhnout
2020-02-13 00:00:0010-QStáhnout
2020-02-12 23:00:0010-QStáhnout
2020-01-15 00:00:008-KStáhnout
2020-01-14 23:00:008-KStáhnout
2020-01-10 00:00:008-KStáhnout
2020-01-09 23:00:008-KStáhnout
2019-12-23 00:00:008-KStáhnout
2019-12-22 23:00:008-KStáhnout
2019-12-09 00:00:008-KStáhnout
2019-12-08 23:00:008-KStáhnout
2019-11-18 00:00:008-KStáhnout
2019-11-17 23:00:008-KStáhnout
2019-11-12 00:00:008-KStáhnout
2019-11-12 00:00:0010-QStáhnout
2019-11-11 23:00:008-KStáhnout
2019-11-11 23:00:0010-QStáhnout
2019-11-08 00:00:008-KStáhnout
2019-11-07 23:00:008-KStáhnout
2019-10-15 01:00:008-KStáhnout
2019-10-15 00:00:008-KStáhnout
2019-09-10 01:00:008-KStáhnout
2019-09-10 00:00:008-KStáhnout
2019-08-14 01:00:008-KStáhnout
2019-08-14 01:00:0010-QStáhnout
2019-08-14 00:00:008-KStáhnout
2019-08-14 00:00:0010-QStáhnout
2019-08-08 01:00:008-KStáhnout
2019-08-08 00:00:008-KStáhnout
2019-06-28 01:00:008-KStáhnout
2019-06-28 01:00:0010-KStáhnout
2019-06-28 00:00:008-KStáhnout
2019-06-28 00:00:0010-KStáhnout
2019-06-13 01:00:008-KStáhnout
2019-06-13 00:00:008-KStáhnout
2019-02-14 00:00:008-KStáhnout
2019-02-14 00:00:0010-QStáhnout
2019-02-13 23:00:008-KStáhnout
2019-02-13 23:00:0010-QStáhnout
2018-11-14 00:00:008-KStáhnout
2018-11-14 00:00:0010-QStáhnout
2018-11-13 23:00:008-KStáhnout
2018-11-13 23:00:0010-QStáhnout
2018-08-30 01:00:008-KStáhnout
2018-08-30 01:00:0010-QStáhnout
2018-08-30 00:00:008-KStáhnout
2018-08-30 00:00:0010-QStáhnout
2018-07-30 01:00:008-KStáhnout
2018-07-30 00:00:008-KStáhnout
2018-07-24 01:00:008-KStáhnout
2018-07-24 00:00:008-KStáhnout
preloader